← SynDRA
TAPRENEPAG
SynDRA canonical compound SYN0033236 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PTGER2 |
|---|
| Mechanism of action | prostaglandin receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- PTGER2 FULL AGONIST
- prostaglandin receptor agonist
- PTGER2 AGONIST
Cross-references
Synonyms
- CP-544326
- CP544326
- PF04217329
- Taprenepag isopropyl
- PF-04217329
- PF-4217329
- 9CD894KUMJ
- RefChem:932569
- DTXCID00148678
- MFCD18633300
- Taprenepag [USAN:INN]
- UNII-9CD894KUMJ
- TAPRENEPAG [INN]
- Taprenepag (USAN/INN)
- TAPRENEPAG [USAN]
- TAPRENEPAG [WHO-DD]
- Taprenepag(CP-544326)?
- GTPL5816
- orb1304459
- SCHEMBL3318549
- SCHEMBL29379291
- EX-A941
- CFB18780
- BDBM50016953
- AKOS030632799
- CS-5590
- AC-36845
- AS-76944
- DA-78195
- HY-14899
- NS00072952
- D09968
- AN-584/43522716
- F870122
- BRD-K88854110-001-01-5
- GNO
Look up TAPRENEPAG in the interactive SynDRA portal →